PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
30-Jul-2020 Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited Jubilant Biosys Limited
30-Jul-2020 NORGINE RECEIVES RoSPA GOLD MEDAL FOR HEALTH AND SAFETY SIXTH YEAR IN A ROW Norgine
30-Jul-2020 Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe Aetion
30-Jul-2020 European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis Celltrion Healthcare
28-Jul-2020 Chair Appointed To Lead NHS Drive To Reduce Health Inequalities NHS England
28-Jul-2020 Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd Swedish Biomimetics 3000®
28-Jul-2020 Chiesi publishes its annual report: Group generates almost €2 billion turnover and obtains B Corp certification in 2019 Chiesi Group
28-Jul-2020 Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® Acacia Pharma Group plc
28-Jul-2020 Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical bacterial infections Destiny Pharma plc
28-Jul-2020 Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV Fund+
28-Jul-2020 Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications Oculis
28-Jul-2020 CPI, the Cell and Gene Therapy Catapult and MicrofluidX announce development of technology to rapidly scale up cell and gene therapy manufacture CPI
28-Jul-2020 European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis Celltrion Healthcare
28-Jul-2020 Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease AstraZeneca
28-Jul-2020 Awarded Contract from Codagenix Inc. New York USA for COVID-19 Vaccine Trial Open Orphan plc
28-Jul-2020 Coulter Partners secures Chief Executive Officer for Optimapharm Optimapharm
28-Jul-2020 Polyphor strengthens financial flexibility with CHF 19.3 million equity-linked financing Polyphor
28-Jul-2020 MSF: COVID-19 test maker Cepheid overcharging the world’s poorest countries MSF UK
28-Jul-2020 Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer AstraZeneca
24-Jul-2020 Idorsia announces financial results for the first half 2020 Idorsia Ltd